Estimating Intracranial Pressure

Introduction to ICP Estimation

The American Association of Neurological Surgeons recommends that ICP cannot be reliably estimated from blood pressure or physical examination findings alone, and direct invasive monitoring with intraventricular catheters or intraparenchymal probes remains the only accurate method for measuring ICP 1

Clinical signs such as Cushing's triad (hypertension, bradycardia, and irregular respirations) appear only when ICP is critically elevated and herniation is imminent, making them unreliable for early detection, as stated by the European Society of Intensive Care Medicine 2
Pupillary changes (anisocoria or bilateral mydriasis) and decerebration signs indicate advanced intracranial hypertension rather than early elevation, according to the American Society of Anesthesiologists 3, 2
The Brain Injury Foundation suggests that CT imaging does not reliably demonstrate cerebral edema, especially in early stages, and visible basal cisterns do not exclude intracranial hypertension 4

The Neurocritical Care Society recommends calculating cerebral perfusion pressure using CPP = MAP - ICP, with MAP measured at the external ear tragus (level of foramen of Monro) to avoid CPP overestimation 3, 5

The American College of Surgeons recommends strong indications for invasive monitoring, including severe traumatic brain injury (GCS ≤8) with abnormal CT scan, inability to perform adequate neurological examination, hemodynamic instability in severe TBI patients, and after intracranial hematoma evacuation with certain preoperative or postoperative conditions 4, 7, 3, 6

The Society of Critical Care Medicine suggests that ICP >20-25 mmHg is generally treated aggressively, with a 3.95× increased mortality risk, and ICP >40 mmHg carries a 6.9× increased mortality risk 4, 7
The American Heart Association recommends targeting CPP: 60-70 mmHg in adults without multimodal monitoring, with CPP <60 mmHg associated with poor neurological outcomes and CPP >90 mmHg potentially worsening vasogenic cerebral edema 3, 5, 7